Force Therapeutics

Digital care platform for orthopedic patients

New York City, New York, United States

About Force Therapeutics

Force Therapeutics focuses on virtual healthcare by providing digital care platforms for orthopedic patients. Their main product is an episode-based platform that uses video and digital tools to engage patients during their recovery, offering personalized content and facilitating communication with care teams. This approach helps standardize care and improve recovery outcomes, setting them apart from competitors through collaboration with over 60 orthopedic centers and a commitment to evidence-based research. The company's goal is to enhance patient care, reduce healthcare costs, and improve outcomes in the orthopedic field.

New York City, New YorkHeadquarters
2010Year Founded
$5.1MTotal Funding
DEBTCompany Stage
Enterprise Software, HealthcareIndustries
11-50Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
401(k) Retirement Plan
401(k) Company Match
Unlimited Paid Time Off
Remote Work Options
Commuter Benefits
Paid Holidays

Risks

Increased competition from digital health startups could erode market share.
Tightening data privacy regulations may impact operations and compliance costs.
Economic downturns could reduce spending on digital health platforms, affecting subscriptions.

Differentiation

Force Therapeutics specializes in digital care platforms for orthopedic patients.
The company collaborates with over 60 leading orthopedic centers for enhanced patient care.
Their episode-based digital care platform reduces care variations and improves recovery outcomes.

Upsides

Integration of AI-driven analytics personalizes rehabilitation plans, enhancing patient outcomes.
Telehealth reimbursement policies expanding to include digital platforms increase market reach.
Rising demand for remote patient monitoring aligns with Force Therapeutics' platform capabilities.

Funding

Total raised$5.06 M
Latest valuation$12.50 M
StageDEBT
DEBT
10/31/2018
$21
SEED
6/30/2016
$2
$12.50 M
EARLY VC
8/31/2013
N/A
$2.50 M